NeoPharm Co Ltd
KOSDAQ:092730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NeoPharm Co Ltd
Accounts Receivables
NeoPharm Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Accounts Receivables
₩12.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
AmorePacific Corp
KRX:090430
|
Accounts Receivables
₩359.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Amorepacific Group
KRX:002790
|
Accounts Receivables
₩388.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Cosmax Inc
KRX:192820
|
Accounts Receivables
₩427.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Accounts Receivables
₩489.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Accounts Receivables
₩333.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's Accounts Receivables?
Accounts Receivables
12.2B
KRW
Based on the financial report for Dec 31, 2025, NeoPharm Co Ltd's Accounts Receivables amounts to 12.2B KRW.
What is NeoPharm Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%
Over the last year, the Accounts Receivables growth was -4%. The average annual Accounts Receivables growth rates for NeoPharm Co Ltd have been 17% over the past three years , 7% over the past five years , and 10% over the past ten years .
